Cypherpunk Technologies Inc. SEC filings CYPH
Cypherpunk Technologies Inc. has 623 filings in SEC EDGAR's recent list, going back to Jan 7, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 18, 2026 |
| DEFA14A | Additional proxy material | Nov 19, 2025 | — |
| DEFA14A | Additional proxy material | Nov 12, 2025 | — |
| DEFA14A | Additional proxy material | Nov 3, 2025 | — |
| DEF 14A | Proxy statement | Nov 3, 2025 | Dec 15, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 24, 2025 | Dec 15, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | May 16, 2024 | — |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jul 2, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 16, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 16, 2023 |
| DEFA14A | Additional proxy material | Mar 24, 2023 | — |
| DEFA14A | Additional proxy material | Jan 23, 2023 | — |
| DEFA14A | Additional proxy material | Jan 17, 2023 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 16, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 15, 2021 |
| DEFA14A | Additional proxy material | Jun 11, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 16, 2020 |
| DEFA14A | Additional proxy material | Feb 13, 2020 | — |
| DEF 14A | Proxy statement | Feb 10, 2020 | Mar 5, 2020 |
| PRE 14A | Preliminary proxy statement | Jan 28, 2020 | Mar 5, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 11, 2019 |
| DEF 14A | Proxy statement | Mar 16, 2018 | May 3, 2018 |
| DEF 14A | Proxy statement | Dec 19, 2017 | Jan 12, 2018 |
| PRE 14A | Preliminary proxy statement | Dec 8, 2017 | Jan 12, 2018 |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1509745
- Former names
- LEAP THERAPEUTICS, INC. (until Nov 12, 2025); Dekkun Corp (until Jan 7, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.